Women at high cardiovascular risk consistently experienced less intensive lipid management and LDL-C goal achievement compared with men, highlighting similar sex differences in risk factors and lipid management across regions and underscore the need for targeted strategies to improve implementation of guideline-directe...
Q. Chan, J. Cegla, J. Cornel et al.· European Heart Journal· 0 citations
In this large, global, real-world study, most patients with CAD at risk of a first MACE were undertreated with LLT and did not achieve recommended LDL-C levels, highlighting substantial gaps between guideline recommendations and real-world practice.
Q. Chan, J. Cegla, J. Cornel et al.· European Heart Journal· 0 citations
These results support using evolocumab to improve survival in high-risk patients who have not experienced a previous myocardial infarction or stroke, including those with high-risk diabetes without qualifying atherosclerosis with low-density lipoprotein-cholesterol ≥ 90 mg/dl or apolipoprotein B ≥ 80 mg/dl.
Robert P. Giugliano, E. Bohula, A. Bellavia et al.· Circulation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.